Magnetic control optical micro-fluidic system for cross-molecular general detection, preparation method and application
By combining rotation, oscillation and gradient magnetic fields on magnetron microfluidic chips, the controllable movement of magnetic rod-shaped probes is achieved, which solves the limitations of cross-molecular detection in the existing technology and achieves high efficiency for proteins and nucleic acid markers At the same time, the detection speed, specificity and stability are improved.
Patent Information
- Application Number
- CN202411204768.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-30
- Publication Date
- 2024-12-03
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing magnetron microfluidic chips cannot achieve universal cross-molecular detection in biological detection, and there is a problem that the probe and the target analyte are insufficiently mixed.
The magnetic optical microfluidic system is adopted, including a microfluidic chip, auxiliary magnetic field, magnetic rod-like capture probe and RPA amplification system. The controllable orientation of the magnetic probe is achieved through the combination of rotating magnetic field, oscillating dispersed magnetic field and gradient magnetic field. Exercise and efficient binding to complete simultaneous detection of protein and nucleic acid markers.
Fast and efficient simultaneous detection of proteins and nucleic acid markers is achieved, and the detection speed, specificity, sensitivity and stability are improved.
Smart Images

Figure CN119064573A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of biological detection, and in particular relates to a magnetically controlled optical microfluidic system for universal cross-molecule detection, a preparation method and an application thereof. Background Art
[0002] Microfluidic detection and analysis chips are the mainstream technology of the new generation of point-of-care testing (POCT) and the most important form of in vitro diagnosis (IVD). Microfluidic chips use micro-electromechanical processing technology to build a microchannel network on the chip, with controllable fluid running through the entire system. The basic operation units involved in the field of biological analysis, such as sample preparation, reaction, separation, and detection, can be integrated into a chip of a few square centimeters or even smaller, and the analysis process can be completed automatically. Due to its miniaturization, integration, and automation, microfluidic chips have broad application prospects in biomarker detection.
[0003] The combination of magnetic control technology and microfluidic chips has further broadened the application scope of microfluidic chips. Magnetic control microfluidic chips are the main body of magnetic control microfluidic chip research, which is the combination of magnetic materials and magnetic control technology. The control methods of magnetic control materials in chips are divided into: separation, transfer, capture, and mixing. In the absence of an external magnetic field, the running path of the magnetic material will be offset under the dual action of magnetic field force and fluid force, thereby performing programmable magnetic sorting.
[0004] At present, the application of magnetically controlled microfluidic chips in the field of biological detection is limited to one type of analyte. The development of a high-throughput, universal multi-target detection platform is of great significance for clinical diagnosis.
[0005] Technical solution of prior art 1:
[0006] Chinese patent CN109870582 provides a multi-target magnetic immunochemiluminescent microfluidic chip detection platform. The sample is injected into the sample loading hole, flows through the liquid flow connection channel, the antibody in the coating area is re-dissolved, and the target complex is formed and captured. The remaining sample flows through the downstream coating area to form a target complex and is captured until each target molecule in the sample is captured separately; then the free non-target molecules are removed with a cleaning solution, and the luminescent liquid is released to flow through each capture area in turn for signal acquisition. This platform integrates sample injection, magnetic absorption efficient capture and separation, and rapid detection, and can realize simultaneous detection of multiple targets on a chip.
[0007] Disadvantages of prior art 1:
[0008] Although this method can realize the simultaneous detection of multiple targets, it only targets antigens and cannot achieve universal detection across molecules.
[0009] Technical solution of the second prior art:
[0010] Invention patent CN211603208U discloses a magnetic particle luminescent microfluidic chip and detection device for multi-marker detection. The chip includes a sample loading section and a mixing zone on the top plate, and a flow guide zone, a reaction zone, a detection zone and a storage section on the bottom plate. The mixing zone has multiple labeled ligands, and the reaction zone has multiple magnetic particle ligands. In addition to the chip, the device also includes a magnet unit for driving the movement of magnetic particles; an extrusion unit for squeezing a cleaning liquid storage section, a luminescent liquid storage section and an air pump; and a detection unit for detecting the luminescent signal in the detection zone. The sample enters from the sample loading section of the top plate, mixes with each labeled ligand in the mixing zone, then enters the flow guide zone, and enters the reaction zone of the bottom plate from the flow guide zone. After that, the magnetic particles of the magnetic particle ligands are driven by an external magnet into different detection zones to achieve simultaneous detection of multiple markers.
[0011] Disadvantages of the second prior art:
[0012] This method suffers from the problem of insufficient mixing of the probe and the target analyte. Summary of the invention
[0013] The purpose of the present invention is to solve the defects of the above-mentioned prior art and to develop a magnetically controlled optical microfluidic system, preparation method and application for universal cross-molecular detection.
[0014] The present invention adopts the following technical solution:
[0015] A magnetically controlled optical microfluidic system for cross-molecule universal detection, comprising: a microfluidic chip, an auxiliary magnetic field, a magnetic rod-shaped capture probe, a long afterglow detection probe and an RPA amplification system, wherein the microfluidic chip comprises a reaction tank, a cleaning tank, a separation tank and two detection tanks;
[0016] The reaction tank is connected to the cleaning tank through a reaction cleaning flow channel, the cleaning tank is directly connected to the separation tank, the end of the separation tank is connected to the nucleic acid detection tank through a separation nucleic acid detection flow channel, and the end of the separation tank is connected to the immune detection tank through a separation immune detection flow channel;
[0017] Auxiliary magnetic fields include rotating magnetic fields, gradient magnetic fields and oscillating dispersed magnetic fields;
[0018] The reaction tank contains two rod-shaped magnetic capture probes of modified nucleic acid and modified capture antibody and labeled antibody, and the reaction tank is arranged with a rotating magnetic field;
[0019] The cleaning tank contains a cleaning liquid, and the cleaning tank is arranged with an oscillating dispersed magnetic field;
[0020] A gradient magnetic field is applied outside the separation tank;
[0021] The nucleic acid detection tank contains an RPA amplification system, which quantitatively detects nucleic acid analytes through the intensity of the fluorescent signal, and the immune detection tank quantitatively detects protein analytes through the luminescence intensity of the signal molecules on the probe surface.
[0022] A method for preparing a magnetically controlled optical microfluidic system for universal cross-molecule detection, comprising:
[0023] Step 1: Preparation of a probe, wherein the probe is a magnetic rod-shaped capture probe;
[0024] Step 2: Construction of a magnetically controlled optical microfluidic system for universal cross-molecular detection;
[0025] Step 3: Preparation of cross-molecular detection chip.
[0026] Furthermore, the preparation of the magnetic rod-shaped capture probe in step 1 comprises:
[0027] Step 101: adding anhydrous sodium acetate to ethylene glycol, and dissolving by ultrasonication to obtain an ethylene glycol solution of sodium acetate;
[0028] Step 102: Add FeCl3·6H2O to another portion of ethylene glycol, dissolve it by ultrasonication, and then add polyethylene glycol to fully dissolve it;
[0029] Furthermore, the FeCl3·6H2O mass ratios for preparing the magnetic rod-shaped immune capture probe and the molecular capture probe are 5:1 respectively. (The synthesis of immune capture probe and molecular capture probe is two independent synthesis processes, and the purpose of different particle sizes is achieved by adjusting the mass ratio of FeCl3·6H2O).
[0030] Step 103: under vigorous magnetic stirring, slowly pour the mixed solution in step 102 into the ethylene glycol solution of sodium acetate to obtain a uniform reaction precursor solution;
[0031] Step 104: transferring the precursor solution to a stainless steel reactor with a polytetrafluoroethylene liner for reaction, washing with deionized water and ethanol for several times to obtain magnetic Fe3O4 particles;
[0032] Furthermore, the reaction conditions of the reactor are: 200° C. for 4 hours.
[0033] Step 105: Re-dispersing the Fe3O4 particles prepared above in a mixed solution of deionized water and isopropanol, and ultrasonicating for 30 minutes to uniformly disperse the Fe3O4 particles;
[0034] Furthermore, the volume ratio of the deionized water to isopropanol is 1:5.
[0035] Step 106: Add ammonia water and tetraethyl orthosilicate, place in a rotary mixer, and react at room temperature for 4 hours. Under the action of a constant external magnetic field, the magnetic Fe3O4 particles attract each other and self-assemble into a rod-like structure. After the reaction is completed, the product is washed with ethanol and deionized water three times each, and then dispersed in ethanol for storage;
[0036] Step 107: Disperse Fe3O4@SiO2 nanorods in ethylene glycol, add 3-aminopropyltriethoxysilane (APTES), and react at room temperature for 24 hours. Collect the product by centrifugation, and wash it with ethanol three times to obtain amino-modified Fe3O4@SiO2 nanorods.
[0037] Step 108: Re-disperse the Fe3O4@SiO2 nanorods in N,N-dimethylformamide (DMF). Add succinic anhydride (SAA) and triethylamine (TEA) to the mixed solution and stir at room temperature for 24 hours. Collect the product by centrifugation and wash it with ethanol three times to obtain Fe3O4@SiO2 nanorods with carboxyl groups.
[0038] Step 109: Disperse the carboxylated Fe3O4@SiO2 nanorods in a morpholineethanesulfonic acid (MES) solution, add EDC solution and NHS solution, vortex mix at room temperature, and react for 1 hour.
[0039] Furthermore, the pH of the MES solution is 6.0.
[0040] Step 110: Wash the reaction product with PBS for 3 times and disperse it in PBS. Add an appropriate amount of capture antibody to the solution and place it in a rotary mixer for reaction for 4 hours;
[0041] Furthermore, the capture antibody is an antibody against the protein marker to be detected.
[0042] Step 111: The reaction product was washed three times with PBS at 4°C and dispersed in PBS. BSA (1%) was added to the solution and reacted for 1 hour to obtain a magnetic rod-shaped immune capture probe;
[0043] Step 112: Disperse the carboxyl-modified Fe3O4@SiO2 nanorods described in step 108 in the MES solution, add the EDC solution and the NHS solution, vortex mix at room temperature, and react for 1 hour;
[0044] Furthermore, the pH of the MES solution is 5.4.
[0045] Step 113: Wash the reaction product three times with MES solution and disperse it in MES solution. Add the amino DNA to the solution and place it in a rotary mixer for reaction for 4 hours;
[0046] Furthermore, the amino-modified DNA is a complementary sequence to the nucleic acid to be detected.
[0047] Step 114: Wash the above reaction product three times and disperse it in a hybridization buffer to obtain a rod-shaped magnetic molecular capture probe.
[0048] Furthermore, the hybridization buffer is Tris buffer (20mM Tris, 140mM NaCl, 2.5mM MgCl26H2O) with a pH of 7.5.
[0049] Furthermore, the auxiliary magnetic field in the magnetically controlled optical microfluidic system for universal cross-molecular detection in step 2 is an existing device, which consists of a power supply module, a signal generator, a power amplifier and a three-axis Helmholtz coil group. It is pre-programmed using currently mature software, and different magnetic field intensities and types can be set by adjusting software parameters.
[0050] Furthermore, the preparation of the cross-molecular detection chip in step 3 as described above includes:
[0051] Step 301: Immerse the silicon wafer after silanization in a cleaning solution for 10 minutes, then rinse it with a large amount of deionized water, and then put the silicon wafer into a rotary rinse dryer to completely dry it;
[0052] Step 302: Turn on the coating machine, pour the photoresist on the center of the silicon wafer, spin-coat the photoresist on the silicon wafer, and perform soft baking;
[0053] Furthermore, the soft baking conditions are 65°C-95°C, programmed temperature, 5°C / min.
[0054] Step 303: placing the spin-coated silicon wafer on the operating table of the photolithography machine, placing a photolithography mask on the silicon wafer, and starting exposure;
[0055] Step 304: Soak the exposed silicon wafer in a petri dish containing a developer, take out the silicon wafer after the pattern is clear and complete, spray wash the developed silicon wafer with acetone, isopropyl alcohol, and deionized water, and place it on an electric baking plate for post-baking;
[0056] Furthermore, the post-baking conditions are 65° C. for 3 minutes and 95° C. for 10 minutes.
[0057] Step 305: Mix the PDMS prepolymer and the curing agent, place in a vacuum drying oven for vacuum treatment for 2 hours, then pour the PDMS mixture on the silicon wafer mold, and then place on a heating plate for curing;
[0058] Furthermore, the mass ratio of the PDMS prepolymer to the curing agent is 10:1.
[0059] Step 306: peeling the PDMS from the silicon wafer and punching holes with a punch pen;
[0060] Step 307: Clean the chip with 3M tape, then place it in a plasma instrument for plasma bonding treatment, align the upper and lower chip components for bonding, place it in an oven for baking, and finally package it with a glass plate.
[0061] The method for detecting immune markers and molecular markers by a magnetically controlled optical microfluidic system for universal cross-molecule detection includes:
[0062] S1: Mix the sample to be tested with two rod-shaped capture probes coupled with antibodies and nucleic acids, and add them to the reaction tank of the cross-molecular detection chip;
[0063] Furthermore, the antibodies and nucleic acids correspond to the proteins and nucleic acid markers to be detected.
[0064] S2: applying a rotating magnetic field to enhance the binding of the protein marker to be detected and the immune capture probe, as well as the binding of the nucleic acid to be detected and the molecular capture probe;
[0065] S3: continue to apply the rotating magnetic field to further promote the formation of a sandwich immune complex between the immune capture probe protein marker complex and the long afterglow detection probe in the reaction tank;
[0066] S4: applying a gradient magnetic field to drive the capture probe-analyte complex to shuttle from the reaction tank to the cleaning tank;
[0067] S5: Apply an oscillating dispersive magnetic field to remove nonspecifically adsorbed molecules on the probe surface;
[0068] S6: applying a gradient magnetic field to drive the capture probe-analyte complex from the cleaning tank into the separation tank. Due to the different particle sizes of the two capture probes, the two complexes enter different detection tanks respectively under the action of the gradient magnetic field and fluid force;
[0069] S7: The capture probe-to-be-tested nucleic acid complex enters the nucleic acid detection tank for recombinase and polymerase amplification (RPA) reaction, and the concentration of the nucleic acid analyte is proportional to the generated fluorescence intensity;
[0070] S8: The double antibody sandwich complex is subjected to long afterglow immunoquantitative detection in the immunoassay tank. Under the irradiation of excitation light, the fluorescence intensity generated by the long afterglow material is proportional to the concentration of HCV core antigen.
[0071] The magnetic microfluidic platform for cross-molecular detection provided by the present invention realizes the controllable directional movement of two magnetic rod-shaped capture probes in the microfluidic chip by controlling the external magnetic field, completes the efficient binding with the object to be detected, and the cleaning, nucleic acid amplification and long afterglow quantitative detection process, thereby realizing rapid and efficient simultaneous detection of protein markers and nucleic acid markers, and improving the detection speed, specificity, sensitivity and stability. BRIEF DESCRIPTION OF THE DRAWINGS
[0072] Figure 1 Schematic diagram of the microfluidic chip design and cross-molecular detection process of the present invention. DETAILED DESCRIPTION
[0073] In order to make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention is described clearly and completely below. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0074] The magnetically controlled optical microfluidic system for cross-molecule universal detection provided by the present invention includes a microfluidic chip, an auxiliary magnetic field, a magnetic rod-shaped capture probe, a long afterglow detection probe and an RPA amplification system. The microfluidic chip includes a reaction tank, a cleaning tank, a separation tank and two detection tanks; the auxiliary magnetic field includes a rotating magnetic field, a gradient magnetic field and an oscillating dispersion magnetic field. The capture efficiency of the magnetic rod-shaped capture probe for the object to be detected is enhanced by applying a rotating magnetic field, the non-specific adsorbed molecules on the surface of the magnetic rod-shaped capture probe are removed by applying an oscillating dispersion magnetic field, and the directional movement of the probe between the functional slots in the chip is driven by applying a gradient magnetic field. The present invention can simply and efficiently complete cross-molecule universal detection with the assistance of three magnetic fields.
[0075] The method provided by the present invention is described in detail below:
[0076] like Figure 1 As shown, a magnetically controlled optical microfluidic system for cross-molecule universal detection includes: a microfluidic chip, an auxiliary magnetic field, a magnetic rod-shaped capture probe, a long afterglow detection probe, and an RPA amplification system. The microfluidic chip includes a reaction tank, a cleaning tank, a separation tank, and two detection tanks;
[0077] The reaction groove and the cleaning groove are circular grooves with the same diameter and depth, the centers of the reaction groove and the cleaning groove are in a straight line, the reaction groove is connected with the cleaning groove through a reaction cleaning flow channel, the depth of the separation groove is the same as the depth of the cleaning groove, the cleaning groove and the separation groove are directly connected, the separation groove is a rectangular groove, the end of the separation groove is connected with the nucleic acid detection groove through a separation nucleic acid detection flow channel, the end of the separation groove is connected with the immune detection groove through a separation immune detection flow channel, the depth of the separation groove is the same as the depth of the nucleic acid detection groove and the immune detection groove, and the nucleic acid detection groove and the immune detection groove are circular grooves with the same diameter.
[0078] Auxiliary magnetic fields include rotating magnetic fields, gradient magnetic fields and oscillating dispersed magnetic fields.
[0079] The reaction tank contains two rod-shaped magnetic capture probes of modified nucleic acid and modified capture antibody and labeled antibody, the two rod-shaped magnetic probes have the same particle size, and the reaction tank is arranged with a rotating magnetic field. With the assistance of the rotating magnetic field, the contact between the analyte in the sample and the magnetic probe is enhanced.
[0080] The cleaning tank contains a cleaning solution and is provided with an oscillating dispersion magnetic field. With the assistance of an external oscillating dispersion magnetic field, non-specifically adsorbed molecules on the surface of the magnetic probe are removed.
[0081] A gradient magnetic field is applied outside the separation tank, and two magnetic probes of different sizes move into different detection tanks through magnetophoresis.
[0082] The nucleic acid detection tank contains an RPA amplification system, which quantitatively detects nucleic acid analytes through the intensity of the fluorescent signal. The immunoassay tank quantitatively detects protein analytes through the luminescence intensity of the signal molecules on the probe surface, and detects and processes the optical signal through the optical detection device.
[0083] The capture efficiency of the magnetic rod-shaped capture probe for the object to be measured is enhanced by applying a rotating magnetic field, the non-specific adsorbed molecules on the surface of the magnetic rod-shaped capture probe are removed by applying an oscillating dispersion magnetic field, and the directional movement of the probe between the functional slots in the chip is driven by applying a gradient magnetic field. The rotating magnetic field, oscillating dispersion magnetic field, and gradient magnetic field are all existing devices, which are composed of a power supply module, a signal generator, a power amplifier, and a three-axis Helmholtz coil group. They are pre-programmed using currently mature software, and different magnetic field strengths and types can be set by adjusting software parameters.
[0084] A method for preparing a magnetically controlled optical microfluidic system for universal cross-molecular detection, comprising:
[0085] Step 1: Preparation of magnetic rod capture probes
[0086] (1) Preparation of Fe3O4: 1.08 g of anhydrous sodium acetate was weighed and added to 15 ml of ethylene glycol, and ultrasonically dissolved to obtain an ethylene glycol solution of sodium acetate. Then, 2.7 g of FeCl3·6H2O was weighed and added to another 15 ml of ethylene glycol, and ultrasonically dissolved. Then, 0.75 g of polyethylene glycol was added. After the mixture was completely dissolved, the mixed solution was slowly poured into the ethylene glycol solution of sodium acetate under vigorous magnetic stirring. After stirring, the obtained uniform reaction precursor solution was transferred to a stainless steel reactor with a polytetrafluoroethylene liner and heated in a constant temperature drying oven at 200°C for 4 h. After cooling to room temperature, the product was collected into a beaker with a magnet, washed with deionized water and ethanol several times, and stored in ethanol for later use to obtain the substrate of the immune capture probe. Other conditions remained unchanged, and the amount of FeCl3·6H2O added was changed to 0.54 g to obtain Fe3O4 nanoparticles of different particle sizes.
[0087] (2) Preparation of rod-shaped Fe3O4@SiO2: Take 5 mg of the two Fe3O4 powders prepared above and redisperse them in a mixed solution of 5 mL deionized water and 25 mL isopropanol. Ultrasonicate for 30 minutes to evenly disperse the Fe3O4 particles. Then add 500 μL of ammonia water and 300 μL of tetraethyl orthosilicate. Place the mixture in a rotary mixer and react at room temperature for 4 hours. Under the action of a constant external magnetic field, the magnetic Fe3O4 particles attract each other and self-assemble into a rod-shaped structure. After the reaction, the product is washed with ethanol and deionized water three times each, and then dispersed in 30 mL of ethanol for storage to obtain rod-shaped Fe3O4@SiO2 of two particle sizes.
[0088] (3) Preparation of Fe3O4@SiO2@Ab: 5 mg of two kinds of Fe3O4@SiO2 nanorods were dispersed in 20 mL of ethylene glycol, and 200 μL of 3-aminopropyltriethoxysilane (APTES) was added to react at room temperature for 24 h. The product was collected by centrifugation at 8000 r / min for 5 min and washed with ethanol three times. The washed product was dispersed in 15 mL of N,N-dimethylformamide (DMF). Then, 105 mg of succinic anhydride (SAA) and 105 μL of triethylamine (TEA) were added to the above mixed solution and stirred at room temperature for 24 h. The silica-coated Fe3O4 nanorods with carboxyl groups were collected by centrifugation at 8000 r / min for 5 min and washed with ethanol three times. 1 mg of Fe3O4@SiO2 nanorods with carboxyl groups was dispersed in 1 mL of MES solution, and then 200 mM EDC solution and NHS solution were added, vortexed and mixed at room temperature, and reacted for 1 h. Then, the reaction product was washed 3 times with PBS at 4°C and dispersed in 1 mL PBS. An appropriate amount of capture antibody (Ab1) was added to the above solution and placed in a rotary mixer for 4 h. Then, the reaction product was washed 3 times with PBS and dispersed in 1 mL PBS. BSA (1%) was added to the mixture and reacted for 1 h to obtain a rod-shaped magnetic immune capture probe;
[0089] (4) Preparation of Fe3O4@SiO2@DNA: 1 mg of the above-mentioned carboxyl-modified Fe3O4@SiO2 nanorods was dispersed in 1 mL MES solution, and then 200 mM EDC solution and NHS solution were added, vortexed and mixed at room temperature, and reacted for 1 h. The reaction product was washed 3 times with MES solution and dispersed in 1 mL MES solution. The amino-modified DNA was added to the above solution and placed in a rotary mixer for 4 h. Then, the reaction product was washed 3 times and dispersed in 1 mL hybridization buffer to obtain a rod-shaped magnetic molecular capture probe.
[0090] Step 2: Build a magnetically controlled optical microfluidic system for universal cross-molecular detection
[0091] The auxiliary magnetic field in the magnetically controlled optical microfluidic system for universal cross-molecular detection is an existing device, which consists of a power supply module, a signal generator, a power amplifier and a three-axis Helmholtz coil group. It is pre-programmed using currently mature software, and different magnetic field intensities and types can be set by adjusting software parameters.
[0092] Step 3: Preparation of cross-molecular detection chip
[0093] (1) Preparation of silicon wafer substrate: Immerse the silicon wafer after silanization in the cleaning solution for 10 minutes, then rinse it with a large amount of deionized water, and then place the silicon wafer in a rotary rinse dryer to completely dry it;
[0094] (2) Spin coating and pre-baking of SU-8 photoresist: Turn on the coating machine and drop the photoresist on the center of the silicon wafer. The silicon wafer is rotated at high speed to spread the colloid, and then rotated at a slower speed to stabilize the thickness of the colloid. The silicon wafer with SU-8 photoresist is heated from 65℃ to 95℃ at a rate of 5℃ / min and soft-baked for 6 minutes;
[0095] (3) Exposure of SU-8 photoresist: Place the spin-coated silicon wafer on the operating table of the photolithography machine, place the photolithography mask on the silicon wafer, and start exposure;
[0096] (4) Development, rinsing and post-baking: Soak the exposed silicon wafer in a petri dish containing developer. After the pattern is clear and complete, take out the silicon wafer, spray the developed silicon wafer with acetone, isopropyl alcohol and deionized water, and place it on an electric baking plate for post-baking (65°C for 3 minutes, 95°C for 10 minutes);
[0097] (5) Preparation of PDMS (polydimethylsiloxane) chip: PDMS prepolymer and curing agent were mixed in a mass ratio of 10:1, placed in a vacuum drying oven for vacuum treatment for 2 h, and then the PDMS mixture was poured on a silicon wafer mold, and then placed on a heating plate for curing at 85 °C for 30 min; PDMS was peeled off from the silicon wafer and holes were punched with a punch pen;
[0098] (6) Bonding and packaging of PDMS chip: Clean the chip with 3M tape, then place it in a plasma instrument for plasma bonding treatment, align the upper and lower chip components, and bake it in an 85°C oven for 48 hours. Finally, package it with a glass plate.
[0099] Experiment: Magnetically controlled optical microfluidic platform for HCV core antigen and HCV nucleic acid detection
[0100] (1) mixing the sample to be tested with two rod-shaped capture probes coupled with anti-HCV core antigen antibodies and HCV complementary nucleic acids, and adding the mixture into the reaction tank of the cross-molecular detection chip;
[0101] (2) applying a rotating magnetic field to enhance the binding of HCV core antigen to the immune capture probe and HCV nucleic acid to the molecular capture probe. There is also a long afterglow detection probe in the reaction tank. The rotating magnetic field can further promote the formation of the sandwich immune complex.
[0102] (3) applying a gradient magnetic field to drive the capture probe-analyte complex to shuttle from the reaction tank to the cleaning tank, and applying an oscillating dispersion magnetic field to remove nonspecifically adsorbed molecules on the probe surface;
[0103] (4) applying a gradient magnetic field to drive the capture probe-analyte complex from the cleaning tank into the separation tank. Due to the different particle sizes of the two capture probes, the two complexes enter different detection tanks under the action of the gradient magnetic field;
[0104] (5) The capture probe-test nucleic acid complex enters the nucleic acid detection tank for recombinase and polymerase amplification (RPA) reaction. The concentration of the nucleic acid analyte is proportional to the fluorescence intensity generated. The double antibody sandwich complex is subjected to long afterglow immunoquantitative detection in the immunoassay tank. Under the irradiation of excitation light, the fluorescence intensity generated by the long afterglow material is proportional to the concentration of HCV core antigen.
[0105] The solution provided by the present invention has the following advantages:
[0106] 1. The magnetic rod-shaped capture probe prepared by the present invention has the advantages of uniform morphology, large specific surface area, controllable movement, good biocompatibility, high stability, and low cost. The capture probe is magnetic due to its Fe3O4 core, and can be driven by an external magnetic field to perform directional movement in the chip. In addition, due to the coating of the SiO2 shell, the Fe3O4 cores attract each other under the action of the gradient magnetic field to form a rod-shaped structure. The silicon layer increases the stability and dispersibility of the probe, which is conducive to surface modification and modification. The rod-shaped structure further increases the specific surface area of the probe, can capture more antibodies, and can respond faster to the magnetic field, which can improve the capture efficiency of the probe and speed up the detection time.
[0107] 2. The long afterglow detection probe used in the present invention has the characteristics of long luminescence lifetime, adjustable optical properties, low cost and delayed luminescence, which can avoid the interference of non-specific signals on the detection signal, and make the detection system have high specificity and high stability. By regulating the luminescence properties of the long afterglow material, several long afterglow luminescent materials with different excitation and emission wavelengths can be prepared to achieve high-throughput detection of multiple immune markers.
[0108] 3. The microfluidic chip prepared by the present invention is designed with a separation slot and two detection slots. By precisely controlling the particle size of the capture probe, the probe is diverted in the separation slot under the dual effects of magnetic field drive and fluid force, and then enters the two pre-designed detection slots, thereby realizing simultaneous cross-molecular detection of immune markers and molecular markers.
[0109] 4. The present invention has built a magnetic field generation and control system with high control accuracy and stable working performance. By adjusting the software parameters, a magnetic field with controllable type, intensity and time can be generated outside the chip to drive the orientation and controllable movement of each component in the chip, complete the incubation of samples and reagents, the cleaning of interferences such as non-specific molecules, the diversion and detection of two complexes, etc.
[0110] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims
1. A magnetically controlled optical microfluidic system for universal cross-molecular detection, It is characterized in that include: A microfluidic chip, an auxiliary magnetic field, a magnetic rod-shaped capture probe, a long afterglow detection probe and an RPA amplification system, wherein the microfluidic chip includes a reaction tank, a cleaning tank, a separation tank and two detection tanks; The reaction tank is connected to the cleaning tank through a reaction cleaning flow channel, the cleaning tank is directly connected to the separation tank, the end of the separation tank is connected to the nucleic acid detection tank through a separation nucleic acid detection flow channel, and the end of the separation tank is connected to the immune detection tank through a separation immune detection flow channel; Auxiliary magnetic fields include rotating magnetic fields, gradient magnetic fields and oscillating dispersed magnetic fields; The reaction tank contains a magnetic rod-shaped capture probe of a modified nucleic acid and a modified capture antibody, a long afterglow detection probe, and a labeled antibody, and a rotating magnetic field is arranged in the reaction tank; The cleaning tank contains a cleaning liquid, and the cleaning tank is arranged with an oscillating dispersed magnetic field; A gradient magnetic field is applied outside the separation tank; The nucleic acid detection tank contains an RPA amplification system, which quantitatively detects nucleic acid analytes through the intensity of the fluorescent signal, and the immune detection tank quantitatively detects protein analytes through the luminescence intensity of the signal molecules on the probe surface.
2. A method for preparing a magnetically controlled optical microfluidic system for universal cross-molecular detection. It is characterized in that include: Step 1: Preparation of a probe, wherein the probe is a magnetic rod-shaped capture probe; Step 101: adding anhydrous sodium acetate to ethylene glycol, and dissolving by ultrasonication to obtain an ethylene glycol solution of sodium acetate; Step 102: Add FeCl 3 6H 2 O is added to another portion of ethylene glycol, dissolved by ultrasonication, and then polyethylene glycol is added to fully dissolve; Step 103: under vigorous magnetic stirring, slowly pour the mixed solution in step 102 into the ethylene glycol solution of sodium acetate to obtain a uniform reaction precursor solution; Step 104: The precursor solution is transferred to a stainless steel reactor with a polytetrafluoroethylene liner for reaction, and washed with deionized water and ethanol for several times to obtain a magnetic Fe 3 O 4 Particles; Step 105: The Fe prepared in step 104 3 O 4 The particles were redispersed in a mixture of deionized water and isopropanol and ultrasonicated for 30 min to 3 O 4 The particles are evenly dispersed; Step 106: Add ammonia water and tetraethyl orthosilicate, place in a rotary mixer, react at room temperature for 4 hours, and under the action of a constant external magnetic field, magnetic Fe 3 O 4 The particles attracted each other and self-assembled into a rod-like structure. After the reaction was completed, the product was washed three times with ethanol and deionized water respectively, and then dispersed in ethanol for storage. Step 107: Fe 3 O 4 @SiO 2 The nanorods were dispersed in ethylene glycol, 3-aminopropyltriethoxysilane was added, and the reaction was carried out at room temperature for 24 h. The product was collected by centrifugation and washed three times with ethanol to obtain the amino-containing Fe 3 O 4 @SiO 2 Nanorods; Step 108: The Fe 3 O 4 @SiO 2 The nanorods were redispersed in N,N-dimethylformamide, succinic anhydride and triethylamine were added to the mixed solution described in step 107, stirred at room temperature for 24 h, centrifuged to collect the product, and washed with ethanol three times to obtain Fe with carboxyl groups. 3 O 4 @SiO 2 Nanorods; Step 109: The carboxylated Fe 3 O 4 @SiO 2 The nanorods were dispersed in morpholineethanesulfonic acid solution, and EDC solution and NHS solution were added, vortexed and mixed at room temperature, and reacted for 1 h; Step 110: Wash the reaction product of step 109 with PBS for 3 times, disperse it in PBS, add an appropriate amount of capture antibody to the above solution, and place it in a rotary mixer for reaction for 4 hours; Step 111: The reaction product of step 110 was washed three times with PBS at 4° C., dispersed in PBS, and added with 1% BSA for reaction for 1 h to obtain a magnetic rod-shaped immune capture probe; Step 112: The carboxyl-modified Fe 3 O 4 @SiO 2 The nanorods were dispersed in the MES solution, and the EDC solution and NHS solution were added, vortexed and mixed at room temperature, and reacted for 1 h; Step 113: Wash the reaction product of step 112 with MES solution for 3 times and disperse it in MES solution, add the amino-modified DNA into the above solution, and place it in a rotary mixer for reaction for 4 hours; Step 114: washing the mixed solution in step 113 three times, dispersing it in a hybridization buffer, and obtaining a rod-shaped magnetic molecular capture probe; Step 2: constructing a magnetically controlled optical microfluidic system for cross-molecule universal detection as claimed in claim 1; Step 3: Preparation of cross-molecular detection chip.
3. The method according to claim 2, It is characterized in that The preparation of the magnetic rod-shaped capture probe in step 1 comprises: The magnetic rod-shaped immune capture probe and the FeCl molecular capture probe 3 6H 2 O mass ratio is 5:1; The reaction conditions of the reactor are: 200°C for 4h; The volume ratio of deionized water to isopropanol is 1:5; The pH of the MES solution is 6.0; The capture antibody is an antibody against the protein marker to be detected; The pH of the MES solution is 5.4; The amino DNA is a complementary sequence to the nucleic acid to be tested; The hybridization buffer is Tris buffer, 20mM Tris, 140mM NaCl, 2.5mM MgCl 2 6H 2 O, pH 7.
5.
4. The method according to claim 2, It is characterized in that Step 3 includes step 301: immersing the silicon wafer after silanization treatment in a cleaning solution for 10 minutes, then cleaning it with a large amount of deionized water, and then placing the silicon wafer in a rotary rinse dryer to completely dry it; Step 302: Turn on the coating machine, pour the photoresist on the center of the silicon wafer, spin-coat the photoresist on the silicon wafer, and perform soft baking; Step 303: placing the spin-coated silicon wafer on the operating table of the photolithography machine, placing a photolithography mask on the silicon wafer, and starting exposure; Step 304: Soak the exposed silicon wafer in a petri dish containing a developer, take out the silicon wafer after the pattern is clear and complete, spray the developed silicon wafer with acetone, isopropyl alcohol, and deionized water, and place it on an electric baking plate for post-baking; Step 305: Mix the PDMS prepolymer and the curing agent, place in a vacuum drying oven for vacuum treatment for 2 hours, then pour the PDMS mixture on the silicon wafer mold, and then place on a heating plate for curing; Step 306: peeling the PDMS from the silicon wafer and punching holes with a punch pen; Step 307: Clean the chip with 3M tape, then place it in a plasma instrument for plasma bonding treatment, align the upper and lower chip components for bonding, place it in an oven for baking, and finally package it with a glass plate.
5. The method according to claim 4, It is characterized in that The preparation of the cross-molecule detection chip in step 3 includes: The soft baking conditions are 65°C-95°C, programmed temperature, 5°C / min; The post-baking conditions are 65°C for 3 minutes and 95°C for 10 minutes; The mass ratio of the PDMS prepolymer to the curing agent is 10:
1.
6. A method for detecting immune markers and molecular markers using the magnetically controlled optical microfluidic system for cross-molecular universal detection as claimed in claim 1, It is characterized in that include: S1: Mix the sample to be tested with two rod-shaped capture probes coupled with antibodies and nucleic acids, and add them to the reaction tank of the cross-molecular detection chip; S2: applying a rotating magnetic field to enhance the binding of the protein marker to be detected and the immune capture probe, as well as the binding of the nucleic acid to be detected and the molecular capture probe; S3: continue to apply the rotating magnetic field to further promote the formation of a sandwich immune complex between the immune capture probe protein marker complex and the long afterglow detection probe in the reaction tank; S4: applying a gradient magnetic field to drive the capture probe-analyte complex to shuttle from the reaction tank to the cleaning tank; S5: Apply an oscillating dispersive magnetic field to remove nonspecifically adsorbed molecules on the probe surface; S6: applying a gradient magnetic field to drive the capture probe-analyte complex from the cleaning tank into the separation tank. Due to the different particle sizes of the two capture probes, the two complexes enter different detection tanks respectively under the action of the gradient magnetic field and fluid force; S7: The capture probe-to-be-tested nucleic acid complex enters the nucleic acid detection tank for recombinase polymerase amplification reaction, and the concentration of the nucleic acid analyte is proportional to the generated fluorescence intensity; S8: The double antibody sandwich complex is subjected to long afterglow immunoquantitative detection in the immunoassay tank. Under the irradiation of excitation light, the fluorescence intensity generated by the long afterglow material is proportional to the concentration of HCV core antigen.
7. The method according to claim 6, wherein the antibodies and nucleic acids correspond to the protein and nucleic acid markers to be detected.
